The Future of Precision Medicine through Clinico-genomic Database
We are on a mission to gather a community of 250,000 individuals. Together, we will innovate and pioneer approaches in disease prevention, treatment, and optimization. Join us in this journey to research the potential of personalized treatment towards longevity across Asia.
Learn More
OneAsa's Journey to Disease free Living
As one of the largest integrated healthcare network in Indonesia, we connect hospitals, clinics, diagnostics and health tech partners, pharmacies, research institutions, and the government access within our comprehensive ecosystem. We firmly believe that the path to longevity starts by understanding the disease, followed by the development of personalized treatments and enhancement of human resilience.
Driven by a mission to extend health span, OneAsa is more than an innovation; we are pushing the boundaries of what's possible in the pursuit of longevity and well-being.
OneAsa's Journey to Disease free Living
As one of the largest integrated healthcare network in Indonesia, we connect hospitals, clinics, diagnostics and health tech partners, pharmacies, research institutions, and the government access within our comprehensive ecosystem. We firmly believe that the path to longevity starts by understanding the disease, followed by the development of personalized treatments and enhancement of human resilience.
Driven by a mission to extend health span, OneAsa is more than an innovation; we are pushing the boundaries of what's possible in the pursuit of longevity and well-being.
As one of the largest integrated healthcare network in Indonesia, we connect hospitals, clinics, diagnostics and health tech partners, pharmacies, research institutions, and the government access within our comprehensive ecosystem. We firmly believe that the path to longevity starts by understanding the disease, followed by the development of personalized treatments and enhancement of human resilience.
Driven by a mission to extend health span, OneAsa is more than an innovation; we are pushing the boundaries of what's possible in the pursuit of longevity and well-being.
600k+
Accessible Patients
6k+
Sample per week
10+
Hospitals
800+
Clinics
1,349+
Ethnicities
25+
Labs
4
Disease Areas of Interest
Our Networks
Our Networks
600k+
Accessible Patients
6k+
Sample per week
10+
Hospitals
800+
Clinics
1,349+
Ethnicities
25+
Labs
4
Disease Areas of Interest
Our Partners
Our Research Fields
for Longevity
Our Research Fields
for Longevity
Our Research Fields
for Longevity
Scientific Projects
Polycystic Ovary Syndrome (PCOS)
Exploring Genetic Polymorphisms in PCOS: Implication for PCOS, Ovarian Response to Gonadotropin and Metabolic Syndrome Occurrence
See Details
Pharmacogenomics
Uncovering Drug Resistance Through PGx in Indonesian Populations.
Providing valuable insights into drug metabolism and clinical applications within the Indonesian population, leveraging Asa Ren’s clinico-genomic datasets.
Metabolic Disease, Collaboration with
Detect early signs of metabolic disease by combining genetic and clinical data to provide personalized preventive programs
CdLS
Biomarker discovery and genomic variations associated with CdLS based on Indonesia populations
Join The Journey Towards Longevity With OneAsa
Join The Journey Towards Longevity With OneAsa
Join The Journey Towards Longevity With OneAsa
Join The Journey Towards Longevity With OneAsa
BIC Building 4th Floor, Jl. Teuku Cik Ditiro No.12, Menteng, Central Jakarta, Indonesia 10350
© 2024 OneAsa. All rights reserved.
How OneAsa Works
Research Topics
BIC Building 4th Floor, Jl. Teuku Cik Ditiro No.12, Menteng, Central Jakarta, Indonesia 10350
© 2024 OneAsa. All rights reserved.
How OneAsa Works
Research Topics
BIC Building 4th Floor, Jl. Teuku Cik Ditiro No.12, Menteng, Central Jakarta, Indonesia 10350
© 2024 OneAsa. All rights reserved.
How OneAsa Works
Research Topics
OneAsa's Journey to Disease free Living
As one of the largest integrated healthcare network in Indonesia, we connect hospitals, clinics, diagnostics and health tech partners, pharmacies, research institutions, and the government access within our comprehensive ecosystem. We firmly believe that the path to longevity starts by understanding the disease, followed by the development of personalized treatments and enhancement of human resilience.
Driven by a mission to extend health span, OneAsa is more than an innovation; we are pushing the boundaries of what's possible in the pursuit of longevity and well-being.
BIC Building 4th Floor, Jl. Teuku Cik Ditiro No.12, Menteng, Central Jakarta, Indonesia 10350
© 2024 OneAsa. All rights reserved.
How OneAsa Works
Research Topics
BIC Building 4th Floor, Jl. Teuku Cik Ditiro No.12, Menteng, Central Jakarta, Indonesia 10350
© 2024 OneAsa. All rights reserved.
How OneAsa Works
Research Topics
Scientific Projects
Polycystic Ovary Syndrome (PCOS)
Exploring Genetic Polymorphisms in PCOS: Implication for PCOS, Ovarian Response to Gonadotropin and Metabolic Syndrome Occurrence
See Details
Pharmacogenomics
Uncovering Drug Resistance Through PGx in Indonesian Populations.
Providing valuable insights into drug metabolism and clinical applications within the Indonesian population, leveraging Asa Ren’s clinico-genomic datasets.
Metabolic Disease, Collaboration with
Detect early signs of metabolic disease by combining genetic and clinical data to provide personalized preventive programs
CdLS
Biomarker discovery and genomic variations associated with CdLS based
on Indonesia populations
Scientific Projects
Polycystic Ovary Syndrome (PCOS)
Exploring Genetic Polymorphisms in PCOS: Implication for PCOS, Ovarian Response to Gonadotropin and Metabolic Syndrome Occurrence
See Details
Pharmacogenomics
Uncovering Drug Resistance Through PGx in Indonesian Populations.
Providing valuable insights into drug metabolism and clinical applications within the Indonesian population, leveraging Asa Ren’s clinico-genomic datasets.
Metabolic Disease, Collaboration with
Detect early signs of metabolic disease by combining genetic and clinical data to provide personalized preventive programs
CdLS
Biomarker discovery and genomic variations associated with CdLS based
on Indonesia populations
Scientific Projects
Polycystic Ovary Syndrome (PCOS)
Exploring Genetic Polymorphisms in PCOS: Implication for PCOS, Ovarian Response to Gonadotropin and Metabolic Syndrome Occurrence
See Details
Pharmacogenomics
Uncovering Drug Resistance Through PGx in Indonesian Populations.
Providing valuable insights into drug metabolism and clinical applications within the Indonesian population, leveraging Asa Ren’s clinico-genomic datasets.
Metabolic Disease, Collaboration with
Detect early signs of metabolic disease by combining genetic and clinical data to provide personalized preventive programs
CdLS
Biomarker discovery and genomic variations associated with CdLS based on Indonesia populations
Scientific Projects
Polycystic Ovary Syndrome (PCOS)
Exploring Genetic Polymorphisms in PCOS: Implication for PCOS, Ovarian Response to Gonadotropin and Metabolic Syndrome Occurrence
See Details
Pharmacogenomics
Uncovering Drug Resistance Through PGx in Indonesian Populations.
Providing valuable insights into drug metabolism and clinical applications within the Indonesian population, leveraging Asa Ren’s clinico-genomic datasets.
Metabolic Disease, Collaboration with
Detect early signs of metabolic disease by combining genetic and clinical data to provide personalized preventive programs
CdLS
Biomarker discovery and genomic variations associated with CdLS based on Indonesia populations
Our Research Fields
for Longevity
Our Research Fields
for Longevity
Scientific Projects
Polycystic Ovary Syndrome (PCOS)
Exploring Genetic Polymorphisms in PCOS: Implication for PCOS, Ovarian Response to Gonadotropin and Metabolic Syndrome Occurrence
See Details
Pharmacogenomics
Uncovering Drug Resistance Through PGx in Indonesian Populations.
Providing valuable insights into drug metabolism and clinical applications within the Indonesian population, leveraging Asa Ren’s clinico-genomic datasets.
Metabolic Disease, Collaboration with
Detect early signs of metabolic disease by combining genetic and clinical data to provide personalized preventive programs
CdLS
Biomarker discovery and genomic variations associated with CdLS based on Indonesia populations
Scientific Projects
Polycystic Ovary Syndrome (PCOS)
Exploring Genetic Polymorphisms in PCOS: Implication for PCOS, Ovarian Response to Gonadotropin and Metabolic Syndrome Occurrence
See Details
Pharmacogenomics
Uncovering Drug Resistance Through PGx in Indonesian Populations.
Providing valuable insights into drug metabolism and clinical applications within the Indonesian population, leveraging Asa Ren’s clinico-genomic datasets.
Metabolic Disease, Collaboration with
Detect early signs of metabolic disease by combining genetic and clinical data to provide personalized preventive programs
CdLS
Biomarker discovery and genomic variations associated with CdLS based on Indonesia populations
Our Networks
600k+
Accessible Patients
6k+
Sample per week
10+
Hospitals
800+
Clinics
1,340+
Ethnicities
25+
Labs
4
Disease Areas of Interest
The Future of Precision Medicine through Clinico-genomic Database
We are on a mission to gather a community of 250,000 individuals. Together, we will innovate and pioneer approaches in disease prevention, treatment, and optimization. Join us in this journey to research the potential of personalized treatment towards longevity across Asia.
Learn More
The Future of Precision Medicine through Clinico-genomic Database
We are on a mission to gather a community of 250,000 individuals. Together, we will innovate and pioneer approaches in disease prevention, treatment, and optimization. Join us in this journey to research the potential of personalized treatment towards longevity across Asia.
Learn More
The Future of Precision Medicine through Clinico-genomic Database
We are on a mission to gather a community of 250,000 individuals. Together, we will innovate and pioneer approaches in disease prevention, treatment, and optimization. Join us in this journey to research the potential of personalized treatment towards longevity across Asia.
Learn More
Our Partners
Our Partners
Our Partners
600k+
Accessible Patients
6k+
Sample per week
10+
Hospitals
800+
Clinics
1,340+
Ethnicities
25+
Labs
Our Networks
4
Disease Areas of Interest